Antibiotics for the common cold [9]

Lancet

Volumn 348, Issue 9029, 1996, Pages 754-755

  Buntinx, F ^a   Van Krunkelsven, P ^a   Morabia, A ^a   Hirschel, B ^a   Mainous A G III, ^a   Hueston, W J ^a   Tyrrell, D A J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AMOXICILLIN; CLAVULANIC ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLINICAL TRIAL; COMMON COLD; COST BENEFIT ANALYSIS; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; LETTER; PRIORITY JOURNAL; RHINITIS; SINUSITIS; STATISTICAL ANALYSIS; DRUG COMBINATION; MICROBIOLOGY; NOTE; CHEMICALLY INDUCED DISORDER; DIARRHEA; VIROLOGY;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CLAVULANIC ACIDS; COMMON COLD; DRUG THERAPY, COMBINATION; HUMANS; RHINITIS; ANTI-BACTERIAL AGENTS; DIARRHEA;

EID: 0041119415     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)65641-3     Document Type: Letter

References (2)

1. L Kaiser D Lew B Hirschel Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions Lancet 347 1996 1507 1510
2. R Wise Antibiotics for the common cold Lancet 347 1996 1499